PharmExec Direct: Having trouble viewing the email? Click Here

IN THIS ISSUE

Pharm Exec’s Top 50 Pharma Companies 2017

Value Frameworks in the US: Not an Echo Chamber

mAb BIOSIMILARS: THE FUTURE OF CANCER TREATMENT?

Top Story
Brexit and EMA: Bidding and Betting on the Future
Pharm Exec's Brussels correspondent Reflector offers review of the top contenders to land the European Medicines Agency as decision on its relocation draws closer
... /Read more/
Advertisement
Through the Patient's Eyes - Needs, Behaviors and the Science Behind it All
On Demand
Learn more
Interview
Health Policy Problem Solver: IFPMA’s Fumie Griego
The International Federation of Pharmaceutical Manufacturers and Associations’ new Assistant Director General, Dr. Fumie Griego speaks about her mission to find real and practical solutions to the most pressing global healthcare challenges
... /Read more/
Advertisement
The Changing Market for Drugs to Treat Orphan Diseases
On Demand
Learn more
Event
Beyond the Science: Commercial Implications from ASCO 2017
Four strategic takeaways from this year's event that are important for pharma oncology leaders, by Maria Whitman and Sharon Karlsberg
... /Read more/
Special Feature
Pharma in the News Spotlight
Pharm Exec’s 13th Annual Press Audit reveals a tonal undercurrent in sync with an industry unable to escape the glare of scrutiny
... /Read more/
UK
New Government Appointment Offers Inside Track on Pricing and Procurement
The UK is entering into unchartered waters between Brexit—offering potentially new approaches to procurement—and negotiating a successor to the PPRS. The government's new recruit Steve Oldfield could give it the inside track, writes Leela Barham
... /Read more/
Calendar
/ August 14–16: 11th Annual Forum on Transparency & Aggregate Spend /
Washington, DC
/ August 16–17: Reimbursement and Access /
Philadelphia, PA
/ August 22–23: Bio/Pharma Forum on Data Science /
Philadelphia, PA
/ September 14-15, 2017: Compliance Congress for Specialty Products /
Boston, MA
/ September 14–15: Risk Based Global Monitoring 2017 /
Barcelona, Spain
/ October 24–25: 12th Annual Value-Based Oncology Management /
Scottsdale, AZ
/ December 12-13: Patient Journey Mapping: From Diagnosis to Treatment /
Philadelphia, PA
/ February 27–28, 2018: Speaker Programs 2018 /
Philadelphia, PA
Industry update
//Glythera Limited (Newcastle Upon Tyne, UK) appointed Dr Mike Owen to the Board as a Non-Executive Director. //Adocia (Lyon, France) named Stanislav Glezer, M.D., MBA, as Chief Medical Officer. //Ablynx (Ghent, Belgium) announced that Hilde Windels will be nominated as an Independent Non-Executive Director at the company’s Special General Meeting to be held on August 18. Mrs. Windels is currently CEO ad interim of Biocartis NV (Mechelen, Belgium). //Nordic Nanovector (Oslo, Norway) appointed Dr. Reza Safaei, MD as Head of Medical Affairs. //
update my profile / advertise with us / print subscribe / digital subscribe / visit pharmexec.com